AbbVie: Breakout! Buying a re-test of supportAbbVie - Short Term - We look to Buy at 119.00 (stop at 114.50)
Previous resistance level of 119.95 broken. A move higher has resulted in prices breaking from the previous range and confirmed our bullish expectation. We have a Gap open at 118.86 from 03/12/2021 to 06/12/2021. Further upside is expected although we prefer to set longs at our bespoke support levels at 119.00, resulting in improved risk/reward.
Our profit targets will be 135.00 and 150.00
Resistance: 122.42 / 124.00 / 130.00
Support: 119.95 / 118.86 / 115.03
Disclaimer – Saxo Bank Group. Please be reminded – you alone are responsible for your trading – both gains and losses. There is a very high degree of risk involved in trading. The technical analysis, like any and all indicators, strategies, columns, articles and other features accessible on/though this site (including those from Signal Centre) are for informational purposes only and should not be construed as investment advice by you. Such technical analysis are believed to be obtained from sources believed to be reliable, but not warrant their respective completeness or accuracy, or warrant any results from the use of the information. Your use of the technical analysis, as would also your use of any and all mentioned indicators, strategies, columns, articles and all other features, is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness (including suitability) of the information. You should assess the risk of any trade with your financial adviser and make your own independent decision(s) regarding any tradable products which may be the subject matter of the technical analysis or any of the said indicators, strategies, columns, articles and all other features.
Please also be reminded that if despite the above, any of the said technical analysis (or any of the said indicators, strategies, columns, articles and other features accessible on/through this site) is found to be advisory or a recommendation; and not merely informational in nature, the same is in any event provided with the intention of being for general circulation and availability only. As such it is not intended to and does not form part of any offer or recommendation directed at you specifically, or have any regard to the investment objectives, financial situation or needs of yourself or any other specific person. Before committing to a trade or investment therefore, please seek advice from a financial or other professional adviser regarding the suitability of the product for you and (where available) read the relevant product offer/description documents, including the risk disclosures. If you do not wish to seek such financial advice, please still exercise your mind and consider carefully whether the product is suitable for you because you alone remain responsible for your trading – both gains and losses.
PHARMA
FENC Analysis - Dip Buy0.786 can be seen as a previous point of resistance
now that price has moved higher than this level, it will be seen as a point of support for the breakdown of the rising wedge , a pattern that is commonly bearish (as you can see on the chart)
Pharmaceutical companies are possibly hot right now, due to the emergence of the new COVID variant.
Buy the Dip.
AcelRx Pharmaceuticals Price TargetsACRX AcelRx Pharmaceuticals is a specialty pharmaceutical company that focuses on the development and commercialization of therapies for the treatment of acute pain.
52 Week Range 0.65 - 2.94
Sitting at all time low now.
HC Wainwright has a 5usd price target for it.
My take profits are:
1: $0.95
2: $1.23
Stop loss: $0.57
TMBR Timber Pharmaceuticals Upside PotentialTMBR Timber Pharmaceuticals had a recent public offering price of $0.64 per share of common stock and accompanying common warrant. The warrants have an exercise price of $0.70 per share.
The price is now 0.47usd
There is a strong upside potential short term!
Price Target 1: $0.85
Price Target 2: $1.37
Stop loss: $0.41
Looking forward to read your opinion about it.
AbCellera: $15 | a Gem under the radar should be the next crispr or illumina ... it supplies stuff to MODERNA
it could be the secret sauce in pre diagnotics or preventing diseases before they become serious
currently winding down and allocation of shares to serious players and strong hands with conviction in the Ai Tech Cum Biologics
Amarin Corporation: A Hidden GemGood afternoon.
I would be glad if you subscribe to me in TradingView so you can be the first to read my new ideas. Overly grateful for your likes. In the comments, you can ask questions about the company.
Summary
Technical analysis
On the chart, we can see the imminent completion of corrective wave 2 and the appearance of impulse wave 3.
Several indicators support the uptrend, including the RSI indicator. In addition, this indicator confirms the Elliott Wave labeling.
On the 1D chart, we can see an open gap in the area of $8.4-12.8 per share.
The company's shares are currently in an uptrend. In addition, Amarin shares are just above the EMA 55 and EMA 89, which also confirms the uptrend.
Fundamental Analysis
You can read a complete fundamental analysis of the company in my analytical article in SA.
Conclusion
Considering the above factors, I believe that the growth of Amarin shares will continue.
Disclosure:
This article may not take into account all the risks and catalysts for the stocks described in it. Any part of this analytical article is provided for informational purposes only, does not constitute an individual investment recommendation, investment idea, advice, offer to buy or sold securities, or other financial instruments. The completeness and accuracy of the information in the analytical article are not guaranteed. If any fundamental criteria or events change in the future, I do not assume any obligation to update this article.
OptiNose: Maximum OptimismGood afternoon.
I would be glad if you subscribe to me in TradingView so you can be the first to read my new ideas. Overly grateful for your likes. In the comments, you can ask questions about the company.
Summary:
Technical analysis:
On the chart, we can see the completion of corrective wave 2 and the emergence of impulse wave 3.
According to the RSI indicator, we can see an uptrend, which confirms the labeling of the Elliott waves.
On the 1D chart, we can see an open gap in the area of $6-7 per share.
Currently, the company's shares are in the area of the downtrend breakout. In addition, Optinose shares have broken through EMA 55 and are just below EMA 89.
Fundamental Analysis:
You can read a complete fundamental analysis of the company in my analytical article in SA.
Conclusion
Considering the above factors, I believe that the growth of Optinose shares will continue.
Disclosure:
This article may not take into account all the risks and catalysts for the stocks described in it. Any part of this analytical article is provided for informational purposes only, does not constitute an individual investment recommendation, investment idea, advice, offer to buy or sold securities, or other financial instruments. The completeness and accuracy of the information in the analytical article are not guaranteed. If any fundamental criteria or events change in the future, I do not assume any obligation to update this article.
$XAIR Symmetrical Triangle BreakBeyond Air has continued a strong uptrend since June. Recently its bin tapering and has shown a symmetrical triangle formation. A Brake out to the upside is likely to continue the uptrend. Watch for a move past the top of the triangle at 11.88 level for conformation and more possible upside. No resistance till 12.50 a high not seen since March 4, 2020
Buy, buy, buy!!!Buy no matter what. I'm in with 40k shares, plan to buy much more for long term ( 5-10 years)
FEMY Femasys Bull PennantOn 7/13/2021 Jonestrading brokerage Initiated Coverage with a Buy rating and a $8.45 Price Target
On 7/13/2021 Chardan Capital brokerage Initiated Coverage with a Buy rating and a $25.00 Price Target
How do you explain such a big difference in valuation?
Where do you see this Bull Pennant heading?
IMVT Immunovant Price TragetsOn 8/13/2021 Chardan Capital brokerage Lowered the Price Target for the Buy rating from $55.00 to $22.00
On 8/10/2021 HC Wainwright brokerage Reiterated Rating to Buy and a Price Target of $19.00
My price target is the strong 14.5usd resistance.
Short Float 12.76%
52 Week Range 6.68 - 53.75
Now the price is 8.95usd
EDIT Editas medicine ready to break outBeen in this for a little while now since the change in market structure and added a few times to this position so not the best avg weighted entry but still well in profit.
Classic sweep of lows and change in market structure has me excited on this position and more recently over the last month with the gap up above the previous short term high and now the ascending triangle forming showing the bulls still buying up and testing that resistance.
The resistance may be strong but we have had a few cracks at it already and eventually I expect this level to break and to see another descent impulse move.
Bullish on EDIT for now, momentum still on our side.